(Q52303702)

29 April 2018

title

Clinical trials of arrhythmia management: methods or madness. (English)

1 reference

29 April 2018

author name string

A J Camm

series ordinal

1

1 reference

29 April 2018

language of work or name

English

0 references

publication date

1 June 1996

1 reference

29 April 2018

Contemporary Clinical Trials

published in

1 reference

29 April 2018

volume

17

1 reference

29 April 2018

issue

3 Suppl

1 reference

29 April 2018

page(s)

4S-16S

1 reference

29 April 2018

The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

A Proposal for Structured Reporting of Randomized Controlled Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

Issues in cardiac pacing: can agism be justified?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

1 reference

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2896%2900068-2

7 January 2021

10.1016/S0197-2456(96)00068-2

Identifiers

DOI

1 reference

29 April 2018

release_fc4izvlqw5gy5ea7o5faeyx4v4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fc4izvlqw5gy5ea7o5faeyx4v4

24 November 2022

mapped directly with Wikidata item

PubMed ID

8877263

1 reference

29 April 2018